Variations nutritionnelles en cours de chimioradiothérapie chez des patients atteints d’un cancer de l’œsophage localement évolué
Antoine Duclos(Université Claude Bernard Lyon 1), F. Di Fiore(Hôpital Charles-Nicolle), Valérie Blondin(Université de Rouen Normandie), Pierre Michel(Aix-Marseille Université), M. Quiesse(Hôpital Charles-Nicolle), Bernard Dubray(Centre Henri Becquerel), Stéphane Lecleire(Inserm), Isabelle Iwanicki–Caron(Centre Hospitalier Universitaire de Rouen)
Cited by 0
Related Papers
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
|The Lancet Oncology|2014|451
The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype
|The American Journal of Gastroenterology|2011|290
A neural network algorithm for detection of GI angiectasia during small-bowel capsule endoscopy
|Gastrointestinal Endoscopy|2018|208
Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer
|The American Journal of Gastroenterology|2007|183
Increased Proteasome-Mediated Degradation of Occludin in Irritable Bowel Syndrome
|The American Journal of Gastroenterology|2009|182